Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference
Karyopharm Therapeutics (Nasdaq: KPTI), a commercial-stage pharmaceutical company focused on novel cancer therapies, has announced its participation in the 2025 RBC Capital Markets Global Healthcare Conference. The company's senior management team will engage in a fireside chat on Wednesday, May 21 at 10:00 a.m. ET in New York. Investors and interested parties can access a live webcast of the presentation through the company's investor relations website, with a replay available after the event.
Karyopharm Therapeutics (Nasdaq: KPTI), un'azienda farmaceutica in fase commerciale specializzata in terapie innovative contro il cancro, ha annunciato la sua partecipazione alla 2025 RBC Capital Markets Global Healthcare Conference. Il team di alta dirigenza dell'azienda parteciper脿 a una conversazione informale il mercoled矛 21 maggio alle 10:00 ET a New York. Investitori e interessati potranno seguire la presentazione in diretta streaming tramite il sito web delle relazioni con gli investitori dell'azienda, con la possibilit脿 di rivederla in differita dopo l'evento.
Karyopharm Therapeutics (Nasdaq: KPTI), una compa帽铆a farmac茅utica en etapa comercial enfocada en terapias innovadoras contra el c谩ncer, ha anunciado su participaci贸n en la Conferencia Global de Salud 2025 de RBC Capital Markets. El equipo directivo senior de la empresa participar谩 en una charla informal el mi茅rcoles 21 de mayo a las 10:00 a.m. ET en Nueva York. Los inversores y partes interesadas podr谩n acceder a una transmisi贸n en vivo de la presentaci贸n a trav茅s del sitio web de relaciones con inversores de la empresa, con una repetici贸n disponible despu茅s del evento.
Karyopharm Therapeutics (雮橃姢雼�: KPTI), 順侅嫚鞝侅澑 鞎� 旃橂鞝滌棎 欷戩爯鞚� 霊� 靸侅梾 雼硠 鞝滌暯 須岇偓臧� 2025 RBC 旌愴敿韮� 毵堨紦 旮�搿滊矊 項姢旒�鞏� 旎嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓鞚� 瓿犾渼 瓴届榿歆勳潃 5鞗� 21鞚� 靾橃殧鞚� 鞓れ爠 10鞁�(霃欕秬鞁滉皠) 雺挫殨鞐愳劀 鞐措Π 韺岇澊鞏挫偓鞚措摐 毂勴寘鞐� 彀胳劃頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愳檧 甏�鞁� 鞛堧姅 攵勲摛鞚� 須岇偓鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 氚滍憸毳� 鞁れ嫓臧� 鞗轨簮鞀ろ姼搿� 鞁滌箔頃� 靾� 鞛堨溂氅�, 頄夓偓 頉� 雼れ嫓氤搓赴 靹滊箘鞀る弰 鞝滉车霅╇媹雼�.
Karyopharm Therapeutics (Nasdaq : KPTI), une entreprise pharmaceutique en phase commerciale sp茅cialis茅e dans les th茅rapies innovantes contre le cancer, a annonc茅 sa participation 脿 la 2025 RBC Capital Markets Global Healthcare Conference. L'茅quipe de direction senior de la soci茅t茅 participera 脿 une discussion informelle le mercredi 21 mai 脿 10h00 ET 脿 New York. Les investisseurs et les parties int茅ress茅es pourront suivre la pr茅sentation en direct via le site web des relations investisseurs de la soci茅t茅, avec une rediffusion disponible apr猫s l'茅v茅nement.
Karyopharm Therapeutics (Nasdaq: KPTI), ein pharmazeutisches Unternehmen in der kommerziellen Phase mit Fokus auf neuartige Krebstherapien, hat seine Teilnahme an der 2025 RBC Capital Markets Global Healthcare Conference angek眉ndigt. Das leitende Management des Unternehmens wird am Mittwoch, den 21. Mai um 10:00 Uhr ET in New York an einem Fireside-Chat teilnehmen. Investoren und Interessierte k枚nnen die Pr盲sentation live 眉ber die Investor-Relations-Website des Unternehmens verfolgen, eine Wiederholung wird nach der Veranstaltung verf眉gbar sein.
- None.
- None.
A live webcast of the fireside chat can be accessed under "Events & Presentations" in the Investor聽section of the Company's website,聽, and will be available for replay following the event.
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. Since its founding, Karyopharm has been an industry leader in oral compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and first颅in颅class, oral exportin 1 (XPO1) inhibitor, XPOVIO庐 (selinexor), is approved in the
XPOVIO庐聽and NEXPOVIO庐聽are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.
View original content to download multimedia:
SOURCE Karyopharm Therapeutics Inc.
FAQ
When is Karyopharm Therapeutics (KPTI) presenting at the RBC Capital Markets Healthcare Conference 2025?
How can investors watch Karyopharm's (KPTI) presentation at the RBC Healthcare Conference?
What type of company is Karyopharm Therapeutics (KPTI)?
Which members of Karyopharm (KPTI) will be presenting at the RBC Conference?
